Cord Blood Transplant With OTS for the Treatment of HIV Positive Hematologic Cancers
Conditions: Acute Erythroid Leukemia; Acute Lymphoblastic Leukemia; Acute Megakaryoblastic Leukemia; Acute Myeloid Leukemia; Blasts Under 10 Percent of Bone Marrow Nucleated Cells; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Chronic Myelogenous Leukemia, BCR-ABL1 Pos itive; Hematopoietic and Lymphoid Cell Neoplasm; Human Immunodeficiency Virus Positive; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Non-Hodgkin Lymphoma; Refractory Anemia Interventions: Drug: Fludarabine; Drug: Fludarabine Phosphate; Drug: Cyclophosphamide; Drug: Thiotepa; Radiation: Total-Body Irradiation; Procedure: Umbilical Cord Blood Transplantation; Other: Cellular Therapy Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anemia | Cancer | Cancer & Oncology | Cardiology | Heart | Heart Transplant | Hematology | Leukemia | Lung Transplant | Lymphoma | Research | Transplant Surgery | Transplants